A molecular docking insight: Phyllanthus niruri L. constituents targeting MMP-9 for angiogenesis inhibition and IL-1beta for antiinflammatory action in endometriosis therapy

In: Plant Science Today · 2024 · doi:10.14719/pst.3224 · W4402964530
article OA: diamond CC0

Abstract

Endometriosis, characterized by inflammatory lesions resembling endometrium outside the uterine cavity, induces chronic inflammation, anatomical changes and persistent pain. The expression of Interleukin 1beta (IL-1beta) is significantly associated with endometriosis, contributing to inflammatory process and fertility issues. Matrix metalloproteinase 9 (MMP-9) is crucial in the adhesion and angiogenesis of endometrial tissue. This study investigates the potential of Phyllanthus niruri L. in inhibiting MMP-9 and IL-1beta through molecular docking analysis. Molecular docking was performed using Discovery Studio Visualizer, Open Babel, PyRx and AutoDock Vina. The inhibitory activities of bioactive compounds on MMP-9 and IL-1beta were predicted. Biological activity and cytotoxicity were assessed using PASS and CLC-Pred respectively. Kaempferol and quercetin from P. niruri exhibited significant MMP-9 expression inhibitory activity. Search Tool for Interacting Chemicals (STITCH) analysis revealed interactions of quercetin and galangin with specific proteins involved in pathways related to endometriosis. Biological activity analysis indicated that quercetin, kaempferol, herbacetin and galangin show potential as MMP -9 expression inhibitors. CLC-Pred analysis suggested high cytotoxicity of kaempferol against glioma. Molecular docking results showed quercetin's potential as an MMP-9 inhibitor and galangin's potential as an IL-1 beta inhibitor. These findings support the therapeutic potential of P. niruri for endometriosis, providing insights for further research in developing innovative therapies targeting endometriosis-related inflammation and angiogenesis.
Full text 6,541 characters · extracted from oa-doi-fallback · click to expand
Endometriosis, characterized by inflammatory lesions resembling endometrium outside the uterine cavity, induces chronic inflammation, anatomical changes and persistent pain. The expression of Interleukin 1beta (IL-1beta) is significantly associated with endometriosis, contributing to inflammatory process and fertility issues. Matrix metalloproteinase 9 (MMP-9) is crucial in the adhesion and angiogenesis of endometrial tissue. This study investigates the potential of Phyllanthus niruri L. in inhibiting MMP-9 and IL-1beta through molecular docking analysis. Molecular docking was performed using Discovery Studio Visualizer, Open Babel, PyRx and AutoDock Vina. The inhibitory activities of bioactive compounds on MMP-9 and IL-1beta were predicted. Biological activity and cytotoxicity were assessed using PASS and CLC-Pred respectively. Kaempferol and quercetin from P. niruri exhibited significant MMP-9 expression inhibitory activity. Search Tool for Interacting Chemicals (STITCH) analysis revealed interactions of quercetin and galangin with specific proteins involved in pathways related to endometriosis. Biological activity analysis indicated that quercetin, kaempferol, herbacetin and galangin show potential as MMP -9 expression inhibitors. CLC-Pred analysis suggested high cytotoxicity of kaempferol against glioma. Molecular docking results showed quercetin's potential as an MMP-9 inhibitor and galangin's potential as an IL-1 beta inhibitor. These findings support the therapeutic potential of P. niruri for endometriosis, providing insights for further research in developing innovative therapies targeting endometriosis-related inflammation and angiogenesis. - Wang Y, Nicholes K, Shih IM. The origin and pathogenesis of endometriosis. Annu Rev Pathol …[Internet]. 2020; Available from: https://www.annualreviews.org/doi/abs/10.1146/annurev-pathmechdis-012419-032654 - Asghari S, Valizadeh A, Aghebati-Maleki L, Nouri M, Yousefi M. Endometriosis: Perspective, lights and shadows of etiology. Biomed Pharmacother. 2018 June;106:163-74. https://doi.org/10.1016/j.biopha.2018.06.109 - Lamceva J, Uljanovs R, Strumfa I. The main theories on the pathogenesis of endometriosis. Int J Mol Sci. 2023;24(5). https://doi.org/10.3390/ijms24054254 - Missmer SA, Tu FF, Agarwal SK. Impact of endometriosis on life-course potential: A narrative review [Internet]. International Journal of General Medicine. ncbi.nlm.nih.gov; 2021. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800443/ - Soliman AM, Surrey E, Bonafede M, Nelson JK, Castelli-Haley J. Real-World evaluation of direct and indirect economic burden among endometriosis patients in the united states. Adv Ther [Internet]. 2018;35(3):408-23. Available from: https://doi.org/10.1007/s12325-018-0667-3 - Swift B, Taneri B, Becker CM, Basarir H, Naci H, Missmer SA et al. Prevalence, diagnostic delay and economic burden of endometriosis and its impact on quality of life: Results from an Eastern Mediterranean population. Eur J Public Health. 2024;34(2):244-52. https://doi.org/10.1093/eurpub/ckad216 - Peng B, Alotaibi FT, Sediqi S, Bedaiwy MA, Yong PJ. Role of interleukin-1? in nerve growth factor expression, neurogenesis and deep dyspareunia in endometriosis. Hum Reprod. 2021;35(4):901-12. https://doi.org/10.1093/humrep/deaa017 - Sikora J, Smycz-Kuba?ska M, Mielczarek-Palacz A, Kondera-Anasz Z. Abnormal peritoneal regulation of chemokine activation—The role of IL-8 in pathogenesis of endometriosis. Am J Reprod Immunol. 2017;77(4):1-8. https://doi.org/10.1111/aji.12622 - Matsuzaki S, Gremeau AS, Pouly JL. Impaired pathogen-induced autophagy and increased IL-1? and TNF? release in response to pathogenic triggers in secretory phase endometrial stromal cells of endometriosis patients. Reprod Biomed Online. 2020;41(5):767-81. https://doi.org/10.1016/j.rbmo.2020.06.011 - Zheng W, Cao L, Xu Z, Ma Y, Liang X. Anti-angiogenic alternative and complementary medicines for the treatment of endometriosis: A review. 2018;2018. https://doi.org/10.1155/2018/4128984 - Ke J, Ye J, Li M, Zhu Z. The role of matrix metalloproteinases in endometriosis?: A potential target. 2021;1-16. - Hasan M, Safarianti S, Ramadhani AF, Khilfi S, Suryawati S, Husna F. Bioactive compounds and in vitro evaluation of Phyllanthus niruri extract as antioxidant and antimicrobial activities. Trends Sci. 2024;21(2). https://doi.org/10.48048/tis.2024.7130 - Jeevani Maheshika Dahanayake PKP, Galappaththy P, Arawwawala AM. A mini-review on therapeutic potentials of Phyllanthus niruri Linn. 2020;4(3):101-08. - Kaur N, Kaur B, Sirhindi G. Phytochemistry and pharmacology of Phyllanthus niruri L.: A review. Phyther Res. 2017;31(7):980-1004. https://doi.org/10.1002/ptr.5825 - Cholet J, Decombat C, Delort L, Gainche M, Berry A, Ogeron C et al. Potential anti-inflammatory and chondroprotective effect of Luzula sylvatica. Int J Mol Sci. 2023;24(1). https://doi.org/10.3390/ijms24010127 - Rashidi Z, Khosravizadeh Z, Talebi A. Overview of biological effects of Quercetin on ovary. Phyther … [Internet]. 2021; Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ptr.6750 - de Morais EF, de Oliveira LQR, Farias Morais HG de, Souto Medeiros MR de, Freitas R de A, Rodini CO et al. The anticancer potential of Kaempferol: A systematic review based on in vitro studies. Cancers (Basel). 2024;16(3):1-30. https://doi.org/10.3390/cancers16030585 - Puthanveedu V, Shameera Ahamed TK, Muraleedharan K. Theoretical insights into Zn2+ chelated complexes of herbacetin for the application in Alzheimer’s disease. Chem Phys Impact [Internet]. 2023;6:100163. Available from: https://doi.org/10.1016/j.chphi.2023.100163 - Jomova K, Cvik M, Orolinova T, Y Alomar S, H Alwasel S, Aldahmash W et al. Antioxidant versus prooxidant properties of the flavonoid, galangin: ROS scavenging activity, flavonoid-DNA interaction, copper-catalyzed Fenton reaction and DNA damage study. J Agric Food Res [Internet]. 2024;16:101112. Available from: https://doi.org/10.1016/j.jafr.2024.101112 - Zheng Q han, Du L yun, Zhao Y, Zhang Z, Piao S lan, Wang Y hang et al. Mechanism of Rhodiola rosea–Euonymus alatus drug pair against rheumatoid arthritis: Network pharmacology and experimental validation. Immunity, Inflamm Dis. 2023;11(12):1-20. https://doi.org/10.1002/iid3.1127 - Machairiotis N, Vasilakaki S, Thomakos N. Inflammatory mediators and pain in endometriosis: A systematic review. Biomedicines. 2021;9(1):1-18. https://doi.org/10.3390/biomedicines9010054 Download data is not yet available.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK